3HENTER J I,ELINDER G,OST A.The FHL study group of histiocyte Society:Diagnostic guideline for hemophagocytic lymphohistoiocytosis[J].Semin Oncol,1991,18:29-33.
4HENTER J I,HORNE A,ARICO M,et al.HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2007,48:124-131.
6CASELLI D,ARIC M.EBMT Paediatric Working Party.The role of BMT in childhood histiocytoses[J].Bone Marrow Transplant,2008,41(Suppl)2:S8-S13.
7HOT A,MADOUX M H,VIARD J P,et al.Successful treatment of cytomegalovirus-associated hemophagocytic syndrome by intravenous immunoglobulins[J].Am J Hematol,2008,83:159-162.
8BALAMUTH N J,NICHOLS K E,PAESSLER M,et al.Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis[J].J Pediatr Hematol Oncol,2007,29:569-573.
二级参考文献7
1Katiao K, Kobayash M , Katayama T,et al . Prognostic factor of haemophagocytic syndrome in adults :analysis of 34 cases [J]. Eur J Haematol ,1997 ,59(2) :247.
2Fietta P , Manganelli P . The hemophagocytic syndrome ( macrophage activation syndrom)[ J]. Minerva Med ,2003,94(1) :19 - 27.
3Karras A , Hermine O. Hemophagocytic syndrome[J]. Rev Med In ,2002 ,23 (9) :768 - 778.
4Imashuku S . Teramura T , Morimoto A, et al . Recent developments in the management of haemophagocytic lymphohistiocytosis [ J ]. Expert Opin Pharmacother , 2001 ,2: 1437.
5Imashukus S. Advances in the management of haemophagocytic syndrome[ J].Int J Hematal, 2000, 72 ( 1 ): 1 - 11.
6Shifltt SI, Kaplan J, Ward DM. Chediak - Higashi Syndrome: a rare disorder of lysosome and lysosome organelles[J]. Pigment Cell Res, 2002, 15(4):251 -257.
